dealbook.blogs.nytimes.com - 8/24/2009
—
Warner Chilcott has agreed to buy Procter & Gamble's prescription drug business, people briefed on the matter told DealBook on Sunday.
Warner Chilcott strikes a healthy deal for P&G unit —
BloggingStocks
The dealmaking continues apace in the drug sector. Today, Warner Chilcott plc (NASDAQ: WCRX ) agreed to shell out $3.1 billion for the global pharma business of Procter & Gamble (NYSE: PG ). The deal is all-cash.
There are several megatrends driving the pharma deals. First, it's getting ...
Procter & Gamble Finds Buyer For Drug Business —
Daily Markets
Warner Chilcott, a specialty drug maker, recently announced plans to acquire Procter & Gamble Co.’s ( PG ) prescription drug business for about $3 billion.
Last December, P&G had announced its intention to restrict making new investments in the pharmaceutical division and divest ...
Warner Chilcott Buys P&G Prescription Drug Business —
Business Pundit
Warner Chilcott (NASDAQ: WCRX), a North Ireland-based specialty drugmaker, today acquired Proctor & Gamble’s prescription drug business for $3.1 bn. The Wall Street Journal reports:
Six banks, led by J.P. Morgan Chase & Co. and Bank of America Corp. and including Credit ...
P&G Sells Drug Unit for $3.1 Billion —
DealBook
Procter & Gamble said Monday that it agreed to sell its pharmaceuticals unit to Warner Chilcott for $3.1 billion in cash, as P&G seeks to focus on its consumer health and personal care businesses.
Lunch Wrap —
FT Alphaville
On FT Alphaville Monday morning,
- European credit is back to normal.
- Goldman's preferiti.
- Bove is braced for more bank failures.
- Can banks' share prices double again?
- Warner Chilcott and the good old (leveraged) days.
- The conglomerate comeback in Pink picks.
- Cheap deposits ...
Warner Chilcott harks back to the good old (leveraged) days —
FT Alphaville
Who said leveraged loans are dead? There were echoes of the good old days of highly leveraged deal-financing with news that specialty drug maker Warner Chilcott is expected to announce as early as Monday the acquisition of Procter & Gamble's prescription-drug business for more than $3bn.
In ...
Warner Chilcott to buy P&G unit for $3bn —
FT Alphaville
Warner Chilcott, a specialty drug maker, is acquiring Procter & Gamble's prescription drug business for about $3bn, reports Reuters. A transaction could be announced on Monday. Six lenders led by Bank of America and JPMorgan will provide up to $4bn of financing, including $1bn to refinance ...